GlassScriptPhysician profile
Andrew G Levitt
NPI 1760773220
$1,514.91
in general payments reported to CMS, 2019-2025
16 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $34.27 · 2022: $489 · 2023: $156 · 2024: $158 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $356.77 | 2022-2025 | |
| Horizon Therapeutics Plc | $348.89 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $166.18 | 2023-2024 | Nuzyra |
| Orthofix Medical, INC. | $121.88 | 2022-2025 | Physio-Stim |
| Smith+Nephew, INC. | $117.97 | 2019-2020 | |
| Osiris Therapeutics INC. | $115.44 | 2019 | |
| Bioventus LLC | $64.84 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $40.16 | 2019-2024 | A.L.P.S. |
| Stryker Corporation | $37.51 | 2023 | Augment Injectable, Ortholoc 3di, Easyfuse |
| Kowa Pharmaceuticals America, INC. | $30.25 | 2022 | |
| Nabriva Therapeutics, Plc | $26.43 | 2022 | |
| Kerecis Limited | $20.29 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Impactortho, INC. | $18.74 | 2025 | |
| Integra Lifesciences Corporation | $18.20 | 2020 | |
| Ibsa Pharma INC. | $17.68 | 2023 | Tirosint, Licart |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medela LLC | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Levitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.